ClinicalTrials.gov
public full text
Public Domain
Effectiveness of Anti-IL-5/IL5R Inhibitors
The goal of this observational study is to assess the response to treatment, in patients 18 years and older diagnosed with severe asthma in whom an IL5/IL5R antagonists was initiated between 2012 and 2020. The main question\[s\] it aims to answer are: * What is the response rate after one year of treatment with IL5/IL5R antagonists. * What is the response and remission rate after one year of treatment with IL5/IL5R antagonists in subjects who fullfilled the original randomized control trials (RCTs) inclusion criteria compared with those who did not.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA)#898126
- Maintenance at Initial Treatment With Sequential Anti-Inflammation Reliever Therapy#900550
- A Study of Brentuximab Vedotin in Patients With Hodgkin Lymphoma Unsuitable for Chemotherapy Due to Age, Frailty or Co-morbidity#1086024
- AMG 853 Phase 2 Study in Subjects With Inadequately Controlled Asthma#805029
- Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL#1138419
Record · ID 841356
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive